Vical (VICL) granted orphan drug destination for treatment of invasive aspergillosis
Tweet Send to a Friend
Vical (NASDAQ: VICL) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
